Literature DB >> 6861377

The late reaction following bronchial provocation with house dust mite allergen. Dependence on arachidonic acid metabolism.

A J Fairfax, J M Hanson, J Morley.   

Abstract

The involvement of arachidonic acid metabolism in early and late bronchial reactions has been studied in four asthmatic subjects sensitive to Dermatophagoides pteronyssinus. Pre-treatment with either indomethacin (an inhibitor of the cyclo-oxygenase pathway) or benoxaprofen (an inhibitor of both cyclo-oxygenase and lipoxygenase pathways) failed to affect the amplitude, but did produce some foreshortening of the early response to allergen. If benoxaprofen is an effective inhibitor of SRS-A formation in vivo, then these observations question the role of SRS-A as a spasmogen in allergen-induced bronchospasm. Both drugs were effective inhibitors of the late reaction, implying involvement of cyclo-oxygenase products (endoperoxides, prostaglandins or thromboxanes) in the genesis of a late response to allergen.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6861377      PMCID: PMC1535850     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  A high-speed liquid chromatographic analysis of indomethacin in plasma.

Authors:  G G Skellern; E G Salole
Journal:  J Chromatogr       Date:  1975-11-26

2.  Bronchial provocation tests in etiologic diagnosis and analysis of asthma.

Authors:  J Pepys; B J Hutchcroft
Journal:  Am Rev Respir Dis       Date:  1975-12

3.  Significance of late reactions after bronchial challenge with house dust mite.

Authors:  J O Warner
Journal:  Arch Dis Child       Date:  1976-12       Impact factor: 3.791

4.  Late asthmatic responses induced by ragweed pollen allergen.

Authors:  D G Robertson; A T Kerigan; F E Hargreave; R Chalmers; J Dolovich
Journal:  J Allergy Clin Immunol       Date:  1974-10       Impact factor: 10.793

5.  The late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies.

Authors:  G O Solley; G J Gleich; R E Jordon; A L Schroeter
Journal:  J Clin Invest       Date:  1976-08       Impact factor: 14.808

6.  Effect of indomethacin in asthma: evidence against a role for prostaglandins in its pathogenesis.

Authors:  A P Smith
Journal:  Br J Clin Pharmacol       Date:  1975-08       Impact factor: 4.335

7.  Immediate and late bronchial obstructive reactions to inhalation of house dust and protective effects of disodium cromoglycate and prednisolone.

Authors:  H Booij-Noord; N G Orie; K De Vries
Journal:  J Allergy Clin Immunol       Date:  1971-12       Impact factor: 10.793

8.  The release of spasmogenic substances from human chopped lung tissue and its inhibition.

Authors:  P J Piper; J L Walker
Journal:  Br J Pharmacol       Date:  1973-02       Impact factor: 8.739

9.  House-dust mite asthma. Results of challenge tests on five criteria with Dermatophagoides pteronyssinus.

Authors:  M K McAllen; E S Assem; K Maunsell
Journal:  Br Med J       Date:  1970-05-30

10.  Release of neutrophil chemotactic activity during immediate hypersensitivity reactions in humans.

Authors:  P C Atkins; M Norman; H Weiner; B Zweiman
Journal:  Ann Intern Med       Date:  1977-04       Impact factor: 25.391

View more
  15 in total

Review 1.  Pharmacotherapy of childhood asthma. An inflammatory disease.

Authors:  H P Van Bever; W J Stevens
Journal:  Drugs       Date:  1992-07       Impact factor: 9.546

Review 2.  Leukocyte activation following IgE dependent mechanisms in bronchial asthma.

Authors:  S R Durham
Journal:  Clin Rev Allergy       Date:  1989

Review 3.  Could NSAIDs have a role as antiasthmatic agents?

Authors:  S Bianco; M G Pieroni; R M Refini; M Robuschi; A Vaghi; P Sestini
Journal:  Drugs       Date:  1994-07       Impact factor: 9.546

Review 4.  Platelet activating factor and asthma.

Authors:  J Morley
Journal:  Agents Actions       Date:  1986-10

5.  Oral nafazatrom in man: effect on inhaled antigen challenge.

Authors:  R W Fuller; N Maltby; R Richmond; C T Dollery; G W Taylor; W Ritter; E Philipp
Journal:  Br J Clin Pharmacol       Date:  1987-06       Impact factor: 4.335

Review 6.  Role of inflammation in the hyperreactivity of the airways in asthma.

Authors:  K F Chung
Journal:  Thorax       Date:  1986-09       Impact factor: 9.139

Review 7.  PAF antagonists. Their potential therapeutic role in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Drugs       Date:  1988-02       Impact factor: 9.546

8.  Platelet activating factor (Paf-acether) may account for late-onset reactions to allergen inhalation.

Authors:  C P Page; D Guerreiro; S Sanjar; J Morley
Journal:  Agents Actions       Date:  1985-03

9.  Lung function and plasma levels of thromboxane B2, 6-ketoprostaglandin F1 alpha and beta-thromboglobulin in antigen-induced asthma before and after indomethacin pretreatment.

Authors:  E G Shephard; L Malan; C M Macfarlane; W Mouton; J R Joubert
Journal:  Br J Clin Pharmacol       Date:  1985-04       Impact factor: 4.335

10.  The effects of an oral thromboxane TP receptor antagonist BAY u 3405, on prostaglandin D2- and histamine-induced bronchoconstriction in asthma, and relationship to plasma drug concentrations.

Authors:  S L Johnston; P G Bardin; J Harrison; W Ritter; J R Joubert; S T Holgate
Journal:  Br J Clin Pharmacol       Date:  1992-11       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.